{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.42","value":"0"}]}]}],"denomUnitsSelected":"lesions","denoms":[{"counts":[{"groupId":"OG000","value":"35"}],"units":"Participants"},{"counts":[{"groupId":"OG000","value":"44"}],"units":"lesions"}],"description":"Patient reported assessment scale of pain, itch, color, and texture. Each element (pain, itch, color, and texture) is graded on a 1-10 scale.\n\nThe lowest score is '1', which corresponds to the situation of normal skin/no symptoms (i.e. not different in color, not different in texture, no itching, no pain). Score 10 equals the largest difference from normal skin (i.e. severely painful, severely itchy, vert different color, very different texture).","dispersionType":"Standard Deviation","groups":[{"description":"All subjects will be treated with the laser at week 0 and week 4. Only assessors will be blinded and rate the dermatofibromas in photographs, they will not know which photos were taken pre-treatment vs. post-treatment to determine efficacy.\n\n1540 nanometer Erbium glass laser: Subjects will receive laser treatment by dermatologist at week 0 and week 4.","id":"OG000","title":"All Subjects"}],"paramType":"MEAN","reportingStatus":"POSTED","timeFrame":"12 weeks","title":"Modified Patient and Observer Scar Assessment Scale Pain Component Comparing Change From Baseline to Week 12.","type":"SECONDARY","typeUnitsAnalyzed":"lesions","unitOfMeasure":"score on a scale"}